ClinicalTrials.gov
public full text
Public Domain
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
A open-label, multi-center 2-year safety study to ascertain the baseline levels of bone marrow fibers in previously treated adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP) and to evaluate the long-term effect of eltrombopag on bone marrow fibers. The study will also describe the long-term safety and tolerability of oral eltrombopag treatment in subjects with chronic ITP.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP#1007300
- Serum Soluble Programmed Death-1 Levels in Adult Immune Thrombocytopenic Purpura Patients and Their Relationship with Disease Duration and Clinical Characteristics#414910
- Diagnostic of Chronic Thrombocytopenia#1150247
- The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)#1214873
- Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC#915277
Record · ID 1378055
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive